rethinkTHC Search
Menu
Study breakdown

Perinatal THC exposure altered dopamine and cannabinoid gene regulation in rats, and CBD reversed the damage

Animal StudyPreliminary evidence
The takeaway

Rats exposed to THC around birth showed lasting changes in dopamine D2 and cannabinoid CB1 receptor gene expression in the prefrontal cortex, along with social withdrawal and cognitive impairment, but peripubertal CBD treatment reversed these abnormalities.

Neuroscience researchers, psychiatrists studying psychosis mechanisms, CBD therapy investigators

CBD reversed THC-induced social withdrawal and cognitive impairment in rats

What the researchers found

Perinatal THC exposure increased both Cnr1 (CB1) and Drd2 (D2 receptor) mRNA levels in the adult rat prefrontal cortex, with reduced DNA methylation at the Drd2 regulatory region. These changes were accompanied by social withdrawal and cognitive impairment. Peripubertal CBD treatment reversed the behavioral abnormalities. Similar DRD2 epigenetic alterations were found in human schizophrenia patients.

Why it matters

This study provides a mechanistic link between early THC exposure and schizophrenia-like changes through epigenetic modification of the dopamine system, and demonstrates that CBD may be able to reverse these alterations during a critical developmental window.

The numbers in context

Increased Cnr1 and Drd2 mRNA in adult prefrontal cortex; reduced DNA methylation at Drd2 regulatory region; lower 2-AG brain levels persisting from neonatal age to adulthood; delayed neonatal reflexes; DRD2 methylation alterations confirmed in human schizophrenia patients

How the study worked

Male rats received perinatal THC exposure and were assessed at neonatal age and adulthood for molecular (gene expression, DNA methylation via pyrosequencing, endocannabinoid levels), behavioral (social interaction, cognition), and neurological (neonatal reflexes) outcomes. Some received peripubertal CBD treatment. DRD2 methylation was also measured in a human schizophrenia cohort.

What this study cannot tell us

Male rats only. Perinatal exposure model (via mother) differs from typical human adolescent use. Small human schizophrenia sample for the translational component. CBD treatment timing (peripubertal) may not reflect realistic intervention windows.

How to read the evidence

Strong mechanistic animal study with a translational human component, but limited by male-only design and small human sample.

When this study was published

Published in 2021.

The bigger picture

The convergence of animal and human data on DRD2 epigenetic changes strengthens the case that early cannabinoid exposure can permanently alter dopamine system regulation, and that CBD intervention during adolescence might offer a preventive strategy.

Questions still open

  • Could CBD treatment later in development or adulthood still reverse THC-induced epigenetic changes? Are similar DRD2 methylation patterns found in cannabis users who do not develop psychosis?

Common questions

How did THC change gene regulation?
THC exposure around birth reduced DNA methylation at the dopamine D2 receptor gene, leading to increased D2 and CB1 receptor expression in the prefrontal cortex. These epigenetic changes persisted into adulthood and were associated with behavioral problems.
How did CBD help?
CBD treatment during the peripubertal period (roughly equivalent to early adolescence) reversed the behavioral abnormalities including social withdrawal and cognitive impairment, suggesting it modulated the altered dopaminergic activity caused by early THC exposure.

Read the original research

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.

Pharmacological research, 164, 105357

Citation

Di Bartolomeo, Martina; Stark, Tibor; Maurel, Oriana Maria; Iannotti, Fabio Arturo; Kuchar, Martin; Ruda-Kucerova, Jana; Piscitelli, Fabiana; Laudani, Samuele; Pekarik, Vladimir; Salomone, Salvatore; Arosio, Beatrice; Mechoulam, Raphael; Maccarrone, Mauro; Drago, Filippo; Wotjak, Carsten T; Di Marzo, Vincenzo; Vismara, Matteo; Dell'Osso, Bernardo; D'Addario, Claudio; Micale, Vincenzo. (2021). Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.. Pharmacological research, 164, 105357. https://doi.org/10.1016/j.phrs.2020.105357

Explore the wider topic